Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Real-world Use and (Cost)-Effectiveness of Adjuvant Trastuzumab in Early Breast Cancer

NCT01894711 is registered in ClinicalTrials.gov with Maastricht University Medical Center as lead sponsor.

NCT NCT01894711
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01894711 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Real-world Use and (Cost)-Effectiveness of Adjuvant Trastuzumab in Early Breast Cancer
Lead sponsor
Maastricht University Medical Center
Phase
Observational
Overall status
Completed
Start date
May 31, 2010
Completion date
May 31, 2013
Enrollment
2,684 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer